[HTML][HTML] Preclinical evidence for combined use of aromatase inhibitors and NSAIDs as preventive agents of tobacco-induced lung cancer
LP Stabile, M Farooqui, B Kanterewicz… - Journal of Thoracic …, 2018 - Elsevier
Introduction A hormonal role in NSCLC development is well documented. We previously
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer
LP Stabile, M Farooqui… - Journal of thoracic …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction A hormonal role in NSCLC development is well documented. We previously
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer
LP Stabile, M Farooqui, B Kanterewicz… - Journal of Thoracic …, 2018 - experts.umn.edu
Introduction: A hormonal role in NSCLC development is well documented. We previously
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
[HTML][HTML] Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer
LP Stabile, M Farooqui, B Kanterewicz… - Journal of Thoracic …, 2018 - jto.org
Introduction A hormonal role in NSCLC development is well documented. We previously
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco …
[HTML][HTML] Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer
LP Stabile, M Farooqui, B Kanterewicz… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
Methods We utilized a tobacco carcinogen-induced lung tumor mouse model [4-
(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK)] to determine whether an AI combined …
(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK)] to determine whether an AI combined …
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.
LP Stabile, M Farooqui, B Kanterewicz… - Journal of Thoracic …, 2017 - europepmc.org
Methods We utilized a tobacco carcinogen-induced lung tumor mouse model by treatment
with 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), to determine whether an AI …
with 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), to determine whether an AI …
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.
LP Stabile, M Farooqui, B Kanterewicz… - Journal of Thoracic …, 2017 - europepmc.org
Methods We utilized a tobacco carcinogen-induced lung tumor mouse model by treatment
with 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), to determine whether an AI …
with 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), to determine whether an AI …